12/09/2024
6:49 AM | Relmada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/04/2024
6:30 AM | Relmada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
8:41 AM | Deep Track Capital, LP (Filed by)
Relmada Therapeutics (Subject)
| Form SC 13G/A | |
10/23/2024
3:27 PM | CASAMENTO CHARLES J (Reporting)
Relmada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
11:15 PM | Relmada Therapeutics (Filer)
| Form EFFECT | |
09/11/2024
4:46 PM | Kelly Paul Edward (Reporting)
Relmada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
4:46 PM | Relmada Therapeutics (Issuer)
Shenouda Maged (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
09/11/2024
4:47 PM | CASAMENTO CHARLES J (Reporting)
Relmada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
4:47 PM | Relmada Therapeutics (Issuer)
TRAVERSA SERGIO (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2024
3:23 PM | Relmada Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
05/29/2024
8:23 PM | CASAMENTO CHARLES J (Reporting)
Relmada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
8:23 PM | Ence Chuck (Reporting)
Relmada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
8:24 PM | Fedeli Fabiana (Reporting)
Relmada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
8:24 PM | GLASSPOOL JOHN (Reporting)
Relmada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
8:24 PM | Kelly Paul Edward (Reporting)
Relmada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
8:24 PM | Relmada Therapeutics (Issuer)
Shenouda Maged (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
8:25 PM | Relmada Therapeutics (Issuer)
TRAVERSA SERGIO (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2024
3:10 PM | Relmada Therapeutics (Filer)
| Form DEF 14A | |
04/09/2024
3:15 PM | Relmada Therapeutics (Filer)
| Form DEFA14A | |
03/06/2024
3:15 PM | PERCEPTIVE ADVISORS LLC (Filed by)
Relmada Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024
7:53 AM | Deep Track Capital, LP (Filed by)
Relmada Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024
6:49 AM | Relmada Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G/A | |
02/13/2024
4:13 PM | Relmada Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
01/31/2024
5:28 PM | Ence Chuck (Reporting)
Relmada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
5:28 PM | Relmada Therapeutics (Issuer)
Shenouda Maged (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
5:29 PM | Relmada Therapeutics (Issuer)
TRAVERSA SERGIO (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2024
3:30 PM | Relmada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
7:11 AM | Relmada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
